Akorn (AKRX) has a profit margin of -55.64%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Mar 2020
Trailing 12 months ending Mar 2020
Akorn (AKRX) currently reports a profit margin of -55.64% as of March 2020. That compares with -67.38% in the prior-year period — up 17.4% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Akorn's profit margin history and peer comparisons.
Akorn's profit margin increased from -67.38% to -55.64% — a 17.4% year-over-year increase (period ending March 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Akorn's profit margin of -55.64% is lower than the Healthcare sector average of 13.89%. That is roughly 500.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Akorn's current -55.64% should be judged against Healthcare norms (sector average: 13.89%) and against AKRX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -55.64%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Akorn, and consider following AKRX for alerts when major investors trade the stock.